CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
87 hedge funds and large institutions have $1.29B invested in China Biologic Products Holdings, Inc. in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 88 → 87 (-1)
27% less capital invested
Capital invested by funds: $1.77B → $1.29B (-$486M)
Holders
87
Holding in Top 10
4
Calls
$30.4M
Puts
$13.2M
Top Buyers
| 1 | +$36.8M | |
| 2 | +$24.1M | |
| 3 | +$16.3M | |
| 4 |
Man Group
London,
United Kingdom
|
+$10.5M |
| 5 |
Goldman Sachs
New York
|
+$8.42M |
Top Sellers
| 1 | -$481M | |
| 2 | -$55.3M | |
| 3 | -$29.4M | |
| 4 |
GAM
Greenwoods Asset Management
Grand Cayman,
Cayman Islands
|
-$21.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.4M |